JAGX JAGUAR HEALTH INC Expansion Plans 8-K Filing 2025 - Product Expansion On April 30, 2025, Jaguar Health, Inc. announced positive proof-of-concept results for crofelemer, showing a 27% reduction in total parenteral nutrition and improved stool frequency in patients with intestinal failure.Get access to all SEC 8-K filings of the JAGUAR HEALTH INC